Restricted use of albumin for spontaneous bacterial peritonitis [5]

Gut

Volumn 56, Issue 4, 2007, Pages 597-599

  Sigal, Samuel H ^a,c   Stanca, Carmen M ^a   Fernandez, Javier ^b   Arroyo, Vicente ^b   Navasa, Miguel ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; MIDODRINE; NORADRENALIN;

BACTERIAL PERITONITIS; DISEASE MARKER; DRUG EFFECT; HEMODYNAMICS; HIGH RISK POPULATION; HUMAN; INCIDENCE; KIDNEY FUNCTION; KIDNEY PERFUSION; LETTER; LIVER FAILURE; MORTALITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

ADULT; AGED; ALBUMINS; BACTERIAL INFECTIONS; CLINICAL PROTOCOLS; FEMALE; HEPATORENAL SYNDROME; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PERITONITIS;

EID: 34147202689     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.113050     Document Type: Letter

References (9)

1. Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994;20:1495-501.
2. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-9.
3. Navasa M, Follo A, Filella X, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998;27:1227-32.
4. Ruiz-del-Arbol L, Urman J, Fernandez J, et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003;38:1210-8.
5. Bories PN, Compillo B, Azoou L, et al. Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1997;25:1328-33.
6. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000;32:142-53.
7. Navasa M, Bosch J, Mastai R, et al. Measurement of hepatic blood flow, hepatic extraction and intrinsic clearance of indocyanine green in patients with cirrhosis. Comparison of a non-invasive pharmacokinetic method with measurements using hepatic vein catheterization. Eur J Gastroenterol Hepatol 1991;3:305-12.
8. Fernandez J, Navasa M, Garcia-Pagan JC, et al. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J Hepatol 2004;41:384-90.
9. Toledo C, Saimeron JM, Rimola A, et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993;17:251-7.